NCT03654105 2026-03-27
SMILE
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Active not recruiting
Clinical Trials
11 trialsNCT05081882 2026-02-18
Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava
University of Florida
Phase 2 Active not recruiting
NCT04634071 2026-02-02
TTOP
University of Kentucky
Phase 2 Completed
NCT03824535 2025-04-09
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
Stanford University
Phase 2 Completed
NCT03069924 2025-01-14
Gain-framed Messages and NRT for Lung Cancer Screening Patients
Medical University of South Carolina
Phase 2 Completed
NCT03232138 2024-12-17
Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers
University of Pittsburgh
Phase 2 Completed
NCT03316170 2021-07-08
Consultation, Advice, and Tailored Support (CATS) for Cancer Survivors
University of Kentucky
Phase 2 Completed
NCT02169271 2020-05-21
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules
National Cancer Institute (NCI)
Phase 2 Completed
NCT01885052 2019-12-09
Evaluation of National Cancer Institute Young Adult Stop-Smoking Program
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01305447 2014-12-16
Getting Physical on Cigarettes - Smoking Cessation & Relapse Prevention
University of Western Ontario, Canada
Phase 2 Completed
NCT00363805 2013-11-28
Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease
University of Arizona
Phase 2 Completed